Find Hydrochlorothiazide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 58-93-5, Hctz, Esidrix, Hypothiazide, Hidrotiazida, Idrotiazide
Molecular Formula
C7H8ClN3O4S2
Molecular Weight
297.7  g/mol
InChI Key
JZUFKLXOESDKRF-UHFFFAOYSA-N
FDA UNII
0J48LPH2TH

Hydrochlorothiazide
A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
Hydrochlorothiazide is a Thiazide Diuretic. The physiologic effect of hydrochlorothiazide is by means of Increased Diuresis.
1 2D Structure

Hydrochlorothiazide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
6-chloro-1,1-dioxo-3,4-dihydro-2H-16,2,4-benzothiadiazine-7-sulfonamide
2.1.2 InChI
InChI=1S/C7H8ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-2,10-11H,3H2,(H2,9,12,13)
2.1.3 InChI Key
JZUFKLXOESDKRF-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl
2.2 Other Identifiers
2.2.1 UNII
0J48LPH2TH
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Dichlothiazide

2. Dihydrochlorothiazide

3. Esidrex

4. Esidrix

5. Hctz

6. Hydrodiuril

7. Hypothiazide

8. Oretic

9. Sectrazide

2.3.2 Depositor-Supplied Synonyms

1. 58-93-5

2. Hctz

3. Esidrix

4. Hypothiazide

5. Hidrotiazida

6. Idrotiazide

7. Megadiuril

8. Newtolide

9. Servithiazid

10. Oretic

11. Vetidrex

12. Chlorosulthiadil

13. Esidrex

14. Dichlotiazid

15. Hydrochlorothiazid

16. Hydrochlorthiazide

17. Hydrodiuretic

18. Hydrosaluric

19. Apresazide

20. Aquarills

21. Aquarius

22. Carozide

23. Dichlotride

24. Diclotride

25. Disalunil

26. Hypothiazid

27. Maschitt

28. Thiuretic

29. Drenol

30. Hidril

31. Hydril

32. Nefrix

33. Hidrochlortiazid

34. Hydrodiuril

35. Hydro-diuril

36. Hydro-aquil

37. Dihydrochlorothiazide

38. Jen-diril

39. Dihydrochlorothiazid

40. Lotensin Hct

41. Dihydrochlorothiazidum

42. Chlorzide

43. Dichlorosal

44. Hidroronol

45. Hydrothide

46. Hydrozide

47. Microzide

48. Moduretic

49. Neoflumen

50. Urodiazin

51. Bremil

52. Cidrex

53. Diaqua

54. Direma

55. Dyazide

56. Fluvin

57. Ivaugan

58. Panurin

59. Ro-hydrazide

60. Neo-codema

61. Acuretic

62. Caplaril

63. Hydrocot

64. Pantemon

65. Thlaretic

66. Timolide

67. Unipres

68. Ziac

69. Zide

70. 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide

71. Dihydrochlorurite

72. Aquazide H

73. Hydro-d

74. 3,4-dihydrochlorothiazide

75. Hydrochlorothiazidum

76. Thiaretic

77. Vaseretic

78. Apo-hydro

79. Lopressor Hct

80. Inderide

81. Dihydrochlorurit

82. Hidroclorotiazida

83. Su 5879

84. Aldactazide

85. Maxzide

86. Prinzide

87. Hydrochlorothiazide Intensol

88. Nci-c55925

89. Component Of Cyclex

90. Component Of Esimil

91. Esidrix (tn)

92. Ser-ap-es

93. Component Of Aldoril

94. Component Of Dyazide

95. Component Of Caplaril

96. Hcz

97. Chlorsulfonamidodihydrobenzothiadiazine Dioxide

98. Component Of Aldactazide

99. Copalia-hct

100. Exforge-hct

101. Imprida-hct

102. Rasilez-hct

103. Dafiro-hct

104. Hydrochlorothiaizide

105. Component Of Butizide Prestabs

106. 2h-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide

107. 6-chloro-1,1-dioxo-3,4-dihydro-2h-1$l^{6},2,4-benzothiadiazine-7-sulfonamide

108. Nsc-53477

109. Diu-melusin

110. 0j48lph2th

111. 6-chloro-7-sulfamoyl-3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxide

112. 6-chloro-3,4-dihydro-(2h)-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide

113. Mls000069619

114. Chebi:5778

115. Chlorizide

116. Disothiazid

117. Hct

118. Hidrosaluretil

119. Novodiurex

120. Spironazide

121. Acesistem

122. Acuilix

123. Aldazida

124. Briazide

125. Catiazida

126. Chlothia

127. Clorana

128. Condiuren

129. Dihydran

130. Diurogen

131. Dixidrasi

132. Esoidrina

133. H.h. 25/25

134. H.h. 50/50

135. Hyclosid

136. Indroclor

137. Manuril

138. Medozide

139. Mictrin

140. Mikorten

141. Modurcen

142. Natrinax

143. Saldiuril

144. Selozide

145. Tandiur

146. Urozide

147. Didral

148. Hytrid

149. Nefrol

150. Unazid

151. Hidro-niagrin

152. Hydro-saluric

153. Raunova Plus

154. 3,4-dihydro-6-chloro-7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide

155. Concor Plus

156. Aquazide-h

157. Neo-flumen

158. Neo-minzil

159. 6-chloro-3,4-dihydro-7-sulfamoyl-2h-1,2,4-benzothiadiazine 1,1-dioxide

160. Hydro Par

161. Nsc53477

162. 6-chloro-1,1-dioxo-3,4-dihydro-2h-1lambda6,2,4-benzothiadiazine-7-sulfonamide

163. 6-chloro-3,4-dihydro-2h-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide

164. Hydro-t

165. Hydrochlorthiazidum

166. Hct-isis

167. Su-5879

168. Cas-58-93-5

169. Mazide 25 Mg

170. Ncgc00015508-08

171. Hydrochlorat

172. Hydrochlorot

173. Smr000035778

174. Idroclorotiazide

175. Diu 25 Vigt

176. Hydrex-semi

177. Aldactazide 25/25

178. Aldectazide 50/50

179. Dihydroxychlorothiazidum

180. Dsstox_cid_713

181. Inderide 80/25

182. Hydrochlorothiazide Form Ii

183. 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide

184. Idroclorotiazide [dcit]

185. Dsstox_rid_75752

186. Dsstox_gsid_20713

187. Hydrochlorzide

188. Ezide

189. Hydrozide Injection, Veterinary

190. Hidroclorotiazida [inn-spanish]

191. Hydrochlorothiazidum [inn-latin]

192. 6-chloro-1,1-dioxo-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide

193. Microzide (tn)

194. Ccris 2082

195. Hsdb 3096

196. Sr-01000000119

197. Einecs 200-403-3

198. Nsc 53477

199. Unii-0j48lph2th

200. Brn 0625101

201. Hydrokraft

202. Idrodiuvis

203. Aquazide

204. Manschitt

205. Urirex

206. Hydropar

207. 6-chloro-1,1-dioxo-3,4-dihydro-2h-1?^{6},2,4-benzothiadiazine-7-sulfonamide

208. 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide

209. Prestwick_263

210. Hydrochloro Thiazide

211. Hyzaar (salt/mix)

212. Mfcd00051765

213. Aldoril (salt/mix)

214. Dutoprol (salt/mix)

215. Inderide (salt/mix)

216. Prinzide (salt/mix)

217. Accuretic (salt/mix)

218. Hydropres (salt/mix)

219. Thiazide, Hydrochloro-

220. Hydrochlorothiazide [usp:inn:ban:jan]

221. Spectrum_000877

222. Opera_id_168

223. Maybridge1_004336

224. Prestwick0_000009

225. Prestwick1_000009

226. Prestwick2_000009

227. Prestwick3_000009

228. Spectrum2_001040

229. Spectrum3_000456

230. Spectrum4_000006

231. Spectrum5_000824

232. Lopac-h-4759

233. Chembl435

234. Tekturna Hct (salt/mix)

235. 2h-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1, 1-dioxide

236. H 4759

237. Cid_3639

238. Schembl9349

239. Lopac0_000614

240. Oprea1_357174

241. Bspbio_000017

242. Bspbio_002132

243. Kbiogr_000351

244. Kbioss_001357

245. Af-614/30832002

246. Bidd:gt0153

247. Divk1c_000289

248. Spectrum1500335

249. Bmcl182567 Compound 6a

250. Spbio_001259

251. Spbio_001938

252. Bpbio1_000019

253. Gtpl4836

254. Hydrochlorothiazide, Crystalline

255. Hydrochlorothiazide [mi]

256. Dtxsid2020713

257. Bdbm13076

258. Component Of Dyazide (salt/mix)

259. Hms500o11

260. Hms553n04

261. Hydrochlorothiazide [inn]

262. Hydrochlorothiazide [jan]

263. Kbio1_000289

264. Kbio2_001357

265. Kbio2_003925

266. Kbio2_006493

267. Kbio3_001352

268. Hydrochlorothiazide [hsdb]

269. Hydrochlorothiazide [iarc]

270. Component Of Caplaril (salt/mix)

271. Ninds_000289

272. Hms1568a19

273. Hms1920d19

274. Hms2091l05

275. Hms2095a19

276. Hms2235i09

277. Hms3259o17

278. Hms3261l10

279. Hms3370p11

280. Hms3428a05

281. Hms3655m21

282. Hms3712a19

283. Hydrochlorothiazide [vandf]

284. Pharmakon1600-01500335

285. Zinc896569

286. Hydrochlorothiazide [mart.]

287. Hydrochlorothiazide Component

288. Bcp22001

289. Hy-b0252

290. Jfd00715

291. Hydrochlorothiazide [usp-rs]

292. Hydrochlorothiazide [who-dd]

293. Hydrochlorothiazide [who-ip]

294. Tox21_110165

295. Tox21_201565

296. Tox21_300292

297. Tox21_500614

298. 3,4-dihydro-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine-1,1-dioxide

299. Ccg-40240

300. Nsc757059

301. S1708

302. Stk315354

303. 3,2,4-benzothiadiazine-1,1-dioxide

304. Hydrochlorothiazide (jp17/usp/inn)

305. Hydrochlorothiazide [ema Epar]

306. Akos000121373

307. Tox21_110165_1

308. Ac-8114

309. Db00999

310. Lp00614

311. Nc00510

312. Nsc-757059

313. Ps-3162

314. Sdccgsbi-0050596.p005

315. Hydrochlorothiazide [green Book]

316. Idi1_000289

317. Wln: T66 Bswm Em Dhj Hg Iszw

318. Hydrochlorothiazide [ep Impurity]

319. Hydrochlorothiazide [orange Book]

320. Ncgc00015508-01

321. Ncgc00015508-02

322. Ncgc00015508-03

323. Ncgc00015508-04

324. Ncgc00015508-05

325. Ncgc00015508-06

326. Ncgc00015508-07

327. Ncgc00015508-09

328. Ncgc00015508-10

329. Ncgc00015508-11

330. Ncgc00015508-12

331. Ncgc00015508-13

332. Ncgc00015508-14

333. Ncgc00015508-16

334. Ncgc00015508-17

335. Ncgc00015508-25

336. Ncgc00021906-03

337. Ncgc00021906-04

338. Ncgc00021906-05

339. Ncgc00021906-06

340. Ncgc00021906-07

341. Ncgc00021906-08

342. Ncgc00254017-01

343. Ncgc00259114-01

344. Ncgc00261299-01

345. Ziac Component Hydrochlorothiazide

346. 8049-49-8

347. Bh164522

348. Hh-50/50

349. Hydrochlorothiazide [ep Monograph]

350. Nci60_004317

351. Component Of Butizide Prestabs (salt/mix)

352. Esimil Component Hydrochlorothiazide

353. Hydrochlorothiazide [usp Monograph]

354. Hydrochlorothiazide 1.0 Mg/ml In Methanol

355. Hydrochlorothiazidum [who-ip Latin]

356. Hyzaar Component Hydrochlorothiazide

357. Sbi-0050596.p004

358. Aldoril Component Hydrochlorothiazide

359. Avalide Component Hydrochlorothiazide

360. Dyazide Component Hydrochlorothiazide

361. Hydrochlorothiazide Component Of Ziac

362. Maxzide Component Hydrochlorothiazide

363. Polycap Component Hydrochlorothiazide

364. Riprazo Component Hydrochlorothiazide

365. Unipres Component Hydrochlorothiazide

366. Ab00052012

367. Dutoprol Component Hydrochlorothiazide

368. Eu-0100614

369. Ft-0650564

370. H1274

371. Prinzide Component Hydrochlorothiazide

372. Rasitrio Component Hydrochlorothiazide

373. Sw196569-3

374. Uniretic Component Hydrochlorothiazide

375. Accuretic Component Hydrochlorothiazide

376. Amturnide Component Hydrochlorothiazide

377. Apresazide Component Hydrochlorothiazide

378. Cam-ap-es Component Hydrochlorothiazide

379. H.r.-50 Component Hydrochlorothiazide

380. Hydrap-es Component Hydrochlorothiazide

381. Hydrochlorothiazde Component Of Toulomi

382. Hydrochlorothiazide 100 Microg/ml In Methanol

383. Hydrochlorothiazide Component Of Esimil

384. Hydrochlorothiazide Component Of Hyzaar

385. Hydropres Component Hydrochlorothiazide

386. Kervezide Component Hydrochlorothiazide

387. Kinzalkomb Component Hydrochlorothiazide

388. Moduretic Component Hydrochlorothiazide

389. Normozide Component Hydrochlorothiazide

390. Pritorplus Component Hydrochlorothiazide

391. Quinaretic Component Hydrochlorothiazide

392. Ser-a-gen Component Hydrochlorothiazide

393. Ser-ap-es Component Hydrochlorothiazide

394. Tolucombi Component Hydrochlorothiazide

395. Tribenzor Component Hydrochlorothiazide

396. Vaseretic Component Hydrochlorothiazide

397. Viskazide Component Hydrochlorothiazide

398. Zestoretic Component Hydrochlorothiazide

399. 6-chloro-3,2,4-benzothiadiazine 1,1-dioxide

400. A19550

401. Aldactazide Component Hydrochlorothiazide

402. Benicar Hct Component Hydrochlorothiazide

403. C07041

404. D00340

405. Diovan Hct Component Hydrochlorothiazide

406. Exforge Hct Component Hydrochlorothiazide

407. H10742

408. Hydra-zide Component Hydrochlorothiazide

409. Hydro-ride Component Hydrochlorothiazide

410. Hydrochlorothiazide Component Of Aldoril

411. Hydrochlorothiazide Component Of Avalide

412. Hydrochlorothiazide Component Of Dutoprol

413. Hydrochlorothiazide Component Of Dyazide

414. Hydrochlorothiazide Component Of Maxzide

415. Hydrochlorothiazide Component Of Prinzide

416. Hydrochlorothiazide Component Of Rasitrio

417. Hydrochlorothiazide Component Of Riprazo

418. Hydrochlorothiazide Component Of Unipres

419. Hydrochlorothiazide Component Of Uniretic

420. Ifirmacombi Component Hydrochlorothiazide

421. Sprimeo-hct Component Hydrochlorothiazide

422. Teveten Hct Component Hydrochlorothiazide

423. Ab00052012-15

424. Ab00052012_16

425. Ab00052012_17

426. Hydro-reserp Component Hydrochlorothiazide

427. Hydrochlorothiazide Component Of Amturnide

428. Hydrochlorothiazide Component Of H.r.-50

429. Hydrochlorothiazide Component Of Hydrap-es

430. Hydrochlorothiazide Component Of Hydropres

431. Hydrochlorothiazide Component Of Moduretic

432. Hydrochlorothiazide Component Of Normozide

433. Hydrochlorothiazide Component Of Tribenzor

434. Hydrochlorothiazide Component Of Vaseretic

435. Hydrochlorothiazide Component Of Viskazide

436. Lotensin Hct Component Hydrochlorothiazide

437. Micardis Hct Component Hydrochlorothiazide

438. Micardisplus Component Hydrochlorothiazide

439. Monopril Hct Component Hydrochlorothiazide

440. Tekturna Hct Component Hydrochlorothiazide

441. 051h765

442. Hydrochlorothiazide 100 Microg/ml In Acetonitrile

443. Hydrochlorothiazide Component Of Aldactazide

444. Hydrochlorothiazide Component Of Apresazide

445. Hydrochlorothiazide Component Of Benicar Hct

446. Hydrochlorothiazide Component Of Cam-ap-es

447. Hydrochlorothiazide Component Of Diovan Hct

448. Hydrochlorothiazide Component Of Exforge Hct

449. Hydrochlorothiazide Component Of Hydra-zide

450. Hydrochlorothiazide Component Of Hydro-ride

451. Hydrochlorothiazide Component Of Ifirmacombi

452. Hydrochlorothiazide Component Of Kinzalkomb

453. Hydrochlorothiazide Component Of Quinaretic

454. Hydrochlorothiazide Component Of Rasilez-hct

455. Hydrochlorothiazide Component Of Ser-a-gen

456. Hydrochlorothiazide Component Of Ser-ap-es

457. Hydrochlorothiazide Component Of Sprimeo-hct

458. Hydrochlorothiazide Component Of Teveten Hct

459. Hydrochlorothiazide Component Of Zestoretic

460. Lopressor Hct Component Hydrochlorothiazide

461. Oreticyl Forte Component Hydrochlorothiazide

462. Q423930

463. Hydrochlorothiazide Component Of Hydro-reserp

464. Hydrochlorothiazide Component Of Lotensin Hct

465. Hydrochlorothiazide Component Of Micardis Hct

466. Hydrochlorothiazide Component Of Micardisplus

467. Hydrochlorothiazide Component Of Monopril Hct

468. Hydrochlorothiazide Component Of Tekturna Hct

469. Hydrochlorothiazide, Meets Usp Testing Specifications

470. Q-201210

471. Serpasil-esidrix Component Hydrochlorothiazide

472. Sr-01000000119-2

473. Sr-01000000119-4

474. Sr-01000000119-6

475. Apresoline-esidrix Component Hydrochlorothiazide

476. Brd-k13078532-001-05-2

477. Hydrochlorothiazide Component Of Lopressor Hct

478. Hydrochlorothiazide Component Of Oreticyl Forte

479. Z56347248

480. Hydrochlorothiazide Component Of Serpasil-esidrix

481. 6-chloro-3,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide

482. 6-chloro-7-sulfamoyl-3,2,4-benzothiadiazine 1,1-dioxide

483. Hydrochlorothiazide Component Of Apresoline-esidrix

484. Hydrochlorothiazide, Drug Standard, 1.0 Mg/ml In Methanol

485. Hydroserpine Plus (r-h-h) Component Hydrochlorothiazide

486. 6-chloro-3,4-dihydro-1,1-dioxo-7-sulfamoyl-1,2,4-benzothiadiazine

487. Hydrochlorothiazide Component Of Hydroserpine Plus (r-h-h)

488. Hydrochlorothiazide, British Pharmacopoeia (bp) Reference Standard

489. Hydrochlorothiazide, European Pharmacopoeia (ep) Reference Standard

490. 3,4-dihydro-6-chloro-7-sulfamyl-1,2, 4-benzothiadiazine-1,1-dioxide

491. 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulphonamide-1,1-dioxide

492. 6-chloro-3,4-dihydro-7-sulfamoyl-2h-1,2, 4-benzothiadiazine 1,1-dioxide

493. 6-chloro-7-sulfamoyl-3, 4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxide

494. 6-chloro-7-sulfamoyl-3,4-dihydro-(2h)-1,2,4-benzothiadiazine 1,1-dioxide

495. 6-chloro-7-sulfamoyl-3,4-dihydrobenzo-1,2,4-thiadiazine-1,1-dioxide

496. 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide

497. Hydrochlorothiazide Component Of Irbesartan/hydrochlorothiazide Teva

498. Hydrochlorothiazide Component Of Irbesartan/hydrochlorothiazide-bms

499. Hydrochlorothiazide, United States Pharmacopeia (usp) Reference Standard

500. Ibersartan/hydrochlorothiazide Zentiva Component Hydrochlorothiazide

501. Irbesartan/hydrochlorothiazide Teva Component Hydrochlorothiazide

502. Irbesartan/hydrochlorothiazide-bms Component Hydrochlorothiazide

503. 2h-1,2, 4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1, 1-dioxide

504. 2h-1,2,4-benzothiadiazine, 6-chloro-3,4-dihydro-7-sulfamoyl-2, 1,1-dioxide

505. 2h-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-,1,1-dioxide

506. 2h-1,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide

507. 6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda,2,4-benzothiadiazine-7-sulfonamide

508. 6-chloro-1,1-dioxo-3,4-dihydro-2h-1$l^{6,2,4-benzothiadiazine-7-sulfonamide

509. 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide 1, 1-dioxide

510. 7-(aminosulfonyl)-6-chloro-3,4-dihydro-(2h)-1,2,4-benzothiadiazine 1,1-dioxide

511. Hydralazine Hydrochloride-hydrochlorothiazide-reserpine Component Hydrochlorothiazide

512. Hydrochlorothiazide Component Of Ibersartan/hydrochlorothiazide Zentiva

513. Hydrochlorothiazide For Peak Identification, European Pharmacopoeia (ep) Reference Standard

514. Hydrochlorothiazide, Pharmaceutical Secondary Standard; Certified Reference Material

515. 125727-50-6

516. Hydrochlorothiazide Component Of Hydralazine Hydrochloride-hydrochlorothiazide-reserpine

517. Hydrochlorothiazide Solution, 1.0 Mg/ml In Methanol, Ampule Of 1 Ml, Certified Reference Material

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 297.7 g/mol
Molecular Formula C7H8ClN3O4S2
XLogP3-0.1
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count1
Exact Mass296.9644758 g/mol
Monoisotopic Mass296.9644758 g/mol
Topological Polar Surface Area135 Ų
Heavy Atom Count17
Formal Charge0
Complexity494
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 12  
Drug NameDyazide
PubMed HealthTriamterene/Hydrochlorothiazide (By mouth)
Drug ClassesDiuretic, Potassium Sparing/Thiazide Combination
Active IngredientHydrochlorothiazide; triamterene
Dosage FormCapsule
RouteOral
Strength37.5mg; 25mg
Market StatusPrescription
CompanyGlaxosmithkline

2 of 12  
Drug NameHydrochlorothiazide
PubMed HealthHydrochlorothiazide (By mouth)
Drug ClassesCardiovascular Agent
Drug LabelHydrochlorothiazide is a diuretic and antihypertensive. It is the 3,4-dihydro derivative of chlorothiazide. It is chemically designated as 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine -7-sulfonamide 1,1-dioxide and has the following structural form...
Active IngredientHydrochlorothiazide
Dosage FormTablet; Capsule
RouteOral
Strength25mg; 50mg; 12.5mg
Market StatusPrescription
CompanyVintage Pharms; Mylan Pharms; Excellium; Unichem; Jubilant Cadista; Apotex; Accord Hlthcare; Alembic Pharms; Sciegen Pharms; Sun Pharm Inds; Aurobindo Pharma; Hikma Pharms; Dava Pharms; Lannett Holdings; Ivax Sub Teva Pharms; Actavis Elizabeth; Ipca Labs;

3 of 12  
Drug NameLotensin hct
PubMed HealthBenazepril/Hydrochlorothiazide (By mouth)
Drug ClassesACE Inhibitor/Thiazide Combination, Antihypertensive, Cardiovascular Agent
Active IngredientBenazepril hydrochloride; hydrochlorothiazide
Dosage FormTablet
RouteOral
Strength25mg; 5mg; 6.25mg; 10mg; 12.5mg; 20mg
Market StatusPrescription
CompanyUs Pharms Holdings I

4 of 12  
Drug NameMicrozide
PubMed HealthHydrochlorothiazide (By mouth)
Drug ClassesCardiovascular Agent
Drug LabelMICROZIDE (hydrochlorothiazide, USP)Capsules 12.5 mg is the 3,4-dihydro derivative of chlorothiazide. Its chemical name is 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide. Its empirical formula is C7H8ClN3O4S2; its mole...
Active IngredientHydrochlorothiazide
Dosage FormCapsule
RouteOral
Strength12.5mg
Market StatusPrescription
CompanyWatson Labs

5 of 12  
Drug NameOretic
PubMed HealthLisinopril/Hydrochlorothiazide (By mouth)
Drug ClassesACE Inhibitor/Thiazide Combination, Antihypertensive, Cardiovascular Agent
Active IngredientHydrochlorothiazide
Dosage FormTablet
RouteOral
Strength50mg
Market StatusPrescription
CompanyAbbvie

6 of 12  
Drug NamePrinzide
Active IngredientHydrochlorothiazide; lisinopril
Dosage FormTablet
RouteOral
Strength10mg; 12.5mg; 20mg
Market StatusPrescription
CompanyMerck

7 of 12  
Drug NameDyazide
PubMed HealthTriamterene/Hydrochlorothiazide (By mouth)
Drug ClassesDiuretic, Potassium Sparing/Thiazide Combination
Active IngredientHydrochlorothiazide; triamterene
Dosage FormCapsule
RouteOral
Strength37.5mg; 25mg
Market StatusPrescription
CompanyGlaxosmithkline

8 of 12  
Drug NameHydrochlorothiazide
PubMed HealthHydrochlorothiazide (By mouth)
Drug ClassesCardiovascular Agent
Drug LabelHydrochlorothiazide is a diuretic and antihypertensive. It is the 3,4-dihydro derivative of chlorothiazide. It is chemically designated as 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine -7-sulfonamide 1,1-dioxide and has the following structural form...
Active IngredientHydrochlorothiazide
Dosage FormTablet; Capsule
RouteOral
Strength25mg; 50mg; 12.5mg
Market StatusPrescription
CompanyVintage Pharms; Mylan Pharms; Excellium; Unichem; Jubilant Cadista; Apotex; Accord Hlthcare; Alembic Pharms; Sciegen Pharms; Sun Pharm Inds; Aurobindo Pharma; Hikma Pharms; Dava Pharms; Lannett Holdings; Ivax Sub Teva Pharms; Actavis Elizabeth; Ipca Labs;

9 of 12  
Drug NameLotensin hct
PubMed HealthBenazepril/Hydrochlorothiazide (By mouth)
Drug ClassesACE Inhibitor/Thiazide Combination, Antihypertensive, Cardiovascular Agent
Active IngredientBenazepril hydrochloride; hydrochlorothiazide
Dosage FormTablet
RouteOral
Strength25mg; 5mg; 6.25mg; 10mg; 12.5mg; 20mg
Market StatusPrescription
CompanyUs Pharms Holdings I

10 of 12  
Drug NameMicrozide
PubMed HealthHydrochlorothiazide (By mouth)
Drug ClassesCardiovascular Agent
Drug LabelMICROZIDE (hydrochlorothiazide, USP)Capsules 12.5 mg is the 3,4-dihydro derivative of chlorothiazide. Its chemical name is 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide. Its empirical formula is C7H8ClN3O4S2; its mole...
Active IngredientHydrochlorothiazide
Dosage FormCapsule
RouteOral
Strength12.5mg
Market StatusPrescription
CompanyWatson Labs

11 of 12  
Drug NameOretic
PubMed HealthLisinopril/Hydrochlorothiazide (By mouth)
Drug ClassesACE Inhibitor/Thiazide Combination, Antihypertensive, Cardiovascular Agent
Active IngredientHydrochlorothiazide
Dosage FormTablet
RouteOral
Strength50mg
Market StatusPrescription
CompanyAbbvie

12 of 12  
Drug NamePrinzide
Active IngredientHydrochlorothiazide; lisinopril
Dosage FormTablet
RouteOral
Strength10mg; 12.5mg; 20mg
Market StatusPrescription
CompanyMerck

4.2 Therapeutic Uses

Antihypertensive Agents; Diuretics; Sodium Chloride Symporter Inhibitors

National Library of Medicine's Medical Subject Headings. Hydrochlorothiazide. Online file (MeSH, 2018). Available from, as of August 29, 2018: https://meshb.nlm.nih.gov/search


/CLINICAL TRIALS/ ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world. The Web site is maintained by the National Library of Medicine (NLM) and the National Institutes of Health (NIH). Each ClinicalTrials.gov record presents summary information about a study protocol and includes the following: Disease or condition; Intervention (for example, the medical product, behavior, or procedure being studied); Title, description, and design of the study; Requirements for participation (eligibility criteria); Locations where the study is being conducted; Contact information for the study locations; and Links to relevant information on other health Web sites, such as NLM's MedlinePlus for patient health information and PubMed for citations and abstracts for scholarly articles in the field of medicine. Hydrochlorothiazide is included in the database.

NIH/NLM; ClinicalTrials.Gov. Available from, as of August 29, 2018: https://clinicaltrials.gov/


Hydrochlorothiazide tablets, USP are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. /Included in US product label/

NIH; DailyMed. Current Medication Information for Hydrochlorothiazide tablet (Updated: September 13, 2017). Available from, as of September 11, 2018: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01f1f478-5493-439f-9b99-f4f82023781c


Hydrochlorothiazide tablets, USP have also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. /Included in US product label/

NIH; DailyMed. Current Medication Information for Hydrochlorothiazide tablet (Updated: September 13, 2017). Available from, as of September 11, 2018: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01f1f478-5493-439f-9b99-f4f82023781c


For more Therapeutic Uses (Complete) data for Hydrochlorothiazide (7 total), please visit the HSDB record page.


4.3 Drug Warning

Hydrochlorothiazide shares the pharmacologic actions, uses, and toxic potentials of the thiazides, and the usual precautions of thiazide administration should be observed.

American Society of Health-System Pharmacists; Drug Information 2018. Bethesda, MD. 2018, p. 2888


Some commercially available formulations of hydrochlorothiazide contain sulfites that may cause allergic-type reactions, including anaphylaxis and life-threatening or less severe asthmatic episodes, in certain susceptible individuals. The overall prevalence of sulfite sensitivity in the general population is unknown but probably low; such sensitivity appears to occur more frequently in asthmatic than in nonasthmatic individuals.

American Society of Health-System Pharmacists; Drug Information 2018. Bethesda, MD. 2018, p. 2888


The following adverse reactions have been reported and, within each category, are listed in the order of decreasing severity. ... Whenever adverse reactions are moderate or severe, thiazide dosage should be reduced or therapy withdrawn.

Table: Adverse Effects with Hydrochlorothiazide Tablet [Table#4434]

NIH; DailyMed. Current Medication Information for Hydrochlorothiazide tablet (Updated: September 13, 2017). Available from, as of September 11, 2018: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01f1f478-5493-439f-9b99-f4f82023781c



The most common signs and symptoms /of overdose/ observed are those caused by electrolyte depletion (hypokalemia, hypochloremia, hyponatremia) and dehydration resulting from excessive diuresis. If digitalis has also been administered, hypokalemia may accentuate cardiac arrhythmias.

NIH; DailyMed. Current Medication Information for Hydrochlorothiazide tablet (Updated: September 13, 2017). Available from, as of September 11, 2018: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01f1f478-5493-439f-9b99-f4f82023781c


For more Drug Warnings (Complete) data for Hydrochlorothiazide (28 total), please visit the HSDB record page.


4.4 Drug Indication

Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy. Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Hydrochlorothiazide prevents the reabsorption of sodium and water from the distal convoluted tubule, allowing for the increased elimination of water in the urine. Hydrochlorothiazide has a wide therapeutic window as dosing is individualized and can range from 25-100mg. Hydrochlorothiazide should be used with caution in patients with reduced kidney or liver function.


5.2 MeSH Pharmacological Classification

Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)


Diuretics

Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)


Sodium Chloride Symporter Inhibitors

Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA. (See all compounds classified as Sodium Chloride Symporter Inhibitors.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
HYDROCHLOROTHIAZIDE
5.3.2 FDA UNII
0J48LPH2TH
5.3.3 Pharmacological Classes
Increased Diuresis [PE]; Potassium-sparing Diuretic [EPC]; Thiazide Diuretic [EPC]; Thiazides [CS]; Decreased Renal K+ Excretion [PE]
5.4 ATC Code

C09DX03

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


C03AA03

S66 | EAWAGTPS | Parent-Transformation Product Pairs from Eawag | DOI:10.5281/zenodo.3754448


C03AA03

S66 | EAWAGTPS | Parent-Transformation Product Pairs from Eawag | DOI:10.5281/zenodo.3754448


C03AA03

S66 | EAWAGTPS | Parent-Transformation Product Pairs from Eawag | DOI:10.5281/zenodo.3754448


C03AA03

S66 | EAWAGTPS | Parent-Transformation Product Pairs from Eawag | DOI:10.5281/zenodo.3754448


C - Cardiovascular system

C03 - Diuretics

C03A - Low-ceiling diuretics, thiazides

C03AA - Thiazides, plain

C03AA03 - Hydrochlorothiazide


5.5 Absorption, Distribution and Excretion

Absorption

An oral dose of hydrochlorothiazide is 65-75% bioavailable, with a Tmax of 1-5 hours, and a Cmax of 70-490ng/mL following doses of 12.5-100mg. When taken with a meal, bioavailability is 10% lower, Cmax is 20% lower, and Tmax increases from 1.6 to 2.9 hours.


Route of Elimination

Hydrochlorothiazide is eliminated in the urine as unchanged hydrochlorothiazide.


Volume of Distribution

The volume of distribution varies widely from one study to another with values of 0.83-4.19L/kg.


Clearance

The renal clearance of hydrochlorothiazide in patients with normal renal function is 285mL/min. Patients with a creatinine clearance of 31-80mL/min have an average hydroxychlorothiazide renal clearance of 75mL/min, and patients with a creatinine clearance of 30mL/min have an average hydroxychlorothiazide renal clearance of 17mL/min.


Hydrochlorothiazide is well absorbed from the GI tract, with an oral bioavailability of approximately 65-75%. Although the rate and extent of absorption have been reported to vary depending on the formulation administered, no studies have been performed to determine the clinical importance (if any) of variations in absorption in patients receiving chronic hydrochlorothiazide therapy. Following oral administration of hydrochlorothiazide at doses of 12.5-100 mg, peak plasma concentrations of 70-490 ng/mL are observed within 1-5 hours of dosing. Food decreases the rate and extent of absorption of hydrochlorothiazide capsules (Microzide). Bioavailability and peak plasma concentrations of the drug were decreased by about 10 and 20%, respectively, when hydrochlorothiazide capsules (Microzide) were administered with food. Times to peak plasma concentration for such capsules were delayed by 1.3 hours (from 1.6 to 2.9 hours). Absorption of hydrochlorothiazide is reduced in patients with heart failure. Approximately 40-68% of the drug is bound to plasma proteins. Hydrochlorothiazide exhibits linear pharmacokinetics. Based on determination of plasma drug concentrations over a period of at least 24 hours, the plasma half-life of hydrochlorothiazide reportedly ranges from 5.6-15 hours. Hydrochlorothiazide apparently is not metabolized and is excreted unchanged in urine. At least 61% of the drug is reportedly eliminated from the body within 24 hours. Increased hydrochlorothiazide plasma concentrations and a prolonged elimination half-life have been reported in patients with renal impairment. The effect of hemodialysis on the elimination of the drug has not been determined.

American Society of Health-System Pharmacists; Drug Information 2018. Bethesda, MD. 2018, p. 2888


Thiazides cross the placental barrier and appear in cord blood. /Thiazides/

NIH; DailyMed. Current Medication Information for Hydrochlorothiazide tablet (Updated: September 13, 2017). Available from, as of September 11, 2018: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01f1f478-5493-439f-9b99-f4f82023781c


/MILK/ Thiazides are excreted in breast milk. /Thiazides/

NIH; DailyMed. Current Medication Information for Hydrochlorothiazide tablet (Updated: September 13, 2017). Available from, as of September 11, 2018: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01f1f478-5493-439f-9b99-f4f82023781c


(14)C-hydrochlorothiazide (hct) was administered orally (n=4) and iv (n=2) to healthy subjects. The gastrointestinal absorption ranged between 60% and 80%, most of it took place in the duodenum and the upper jejunum. The radioactivity was eliminated mainly in the urine, while no sigificant biliary excretion was observed. Chromatographic analysis of the urinary radioactivity demonstrated that greater than 95% of the absorbed or injected (14)C-hct was excreted unchanged. The radioactivity in plasma during the first 10 hr after oral administration declined with a fast phase but the levels of label thereafter suggested a slow phase. The existence of such a phase was verified in 1 subject given 75 mg hct orally. His plasma levels of hct (determined with gas-liquid chromatography) declined according to a 2-compartment model, the half-lives of the alpha-and beta-phases being 1.7 and 13.1 hr, respectively. Hct accumulated in the blood cells and the ratio between the radioactivity in cells and that in plasma averaged 3.5. The fate of a single dose of (14)C-hct in 2 hypertensive patients treated with the drug chronically was similar to that in the healthy subjects. A third patient, who had slightly elevated serum creatinine, eliminated hct more slowly than the others. Like the healthy subjects, the patients eliminated hct to greater than 95% in unchanged form.

PMID:1277708 Beermann B et al; Clin Pharmacol Ther 19 (5 Pt 1): 531-7 (1976)


For more Absorption, Distribution and Excretion (Complete) data for Hydrochlorothiazide (6 total), please visit the HSDB record page.


5.6 Metabolism/Metabolites

Hydrochlorothiazide is not metabolized.


5.7 Biological Half-Life

The plasma half life of hydrochlorothiazide is 5.6-14.8h.


Based on determination of plasma drug concentrations over a period of at least 24 hours, the plasma half-life of hydrochlorothiazide reportedly ranges from 5.6-15 hours.

American Society of Health-System Pharmacists; Drug Information 2018. Bethesda, MD. 2018, p. 2888


The bioavailability of hydrochlorothiazide from 50-mg oral tablet doses was examined in healthy male volunteers under fasting and nonfasting conditions. ... The pharmacokinetics of hydrochlorothiazide in plasma could be described in terms of a triexponential function, and the mean half-life determined from the 3 exponents were 1.0, 2.2, and 9.0 hr.

PMID:7062255 Barbhaiya RH et al; J Pharm Sci 71 (2): 245-8 (1982)


The radioactivity in /human/ plasma during the first 10 hr after oral administration /of hydrochlorothiazide (hct)/ declined with a fast phase but the levels of label thereafter suggested a slow phase. The existence of such a phase was verified in 1 subject given 75 mg hct orally. His plasma levels of hct (determined with gas-liquid chromatography) declined according to a 2-compartment model, the half-lives of the alpha-and beta-phases being 1.7 and 13.1 hr, respectively.

PMID:1277708 Beermann B et al; Clin Pharmacol Ther 19 (5 Pt 1): 531-7 (1976)


5.8 Mechanism of Action

Hydrochlorothiazide is transported from the circulation into epithelial cells of the distal convoluted tubule by the organic anion transporters OAT1, OAT3, and OAT4. From these cells, hydrochlorothiazide is transported to the lumen of the tubule by multidrug resistance associated protein 4 (MRP4). Normally, sodium is reabsorbed into epithelial cells of the distal convoluted tubule and pumped into the basolateral interstitium by a sodium-potassium ATPase, creating a concentration gradient between the epithelial cell and the distal convoluted tubule that promotes the reabsorption of water. Hydrochlorothiazide acts on the proximal region of the distal convoluted tubule, inhibiting reabsorption by the sodium-chloride symporter, also known as Solute Carrier Family 12 Member 3 (SLC12A3). Inhibition of SLC12A3 reduces the magnitude of the concentration gradient between the epithelial cell and distal convoluted tubule, reducing the reabsorption of water.


DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - 25MG;25MG

USFDA APPLICATION NUMBER - 12616

read-more

DOSAGE - TABLET;ORAL - 50MG;50MG

USFDA APPLICATION NUMBER - 12616

read-more

DOSAGE - CAPSULE;ORAL - 25MG;37.5MG **Federal...DOSAGE - CAPSULE;ORAL - 25MG;37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 16042

read-more

DOSAGE - TABLET;ORAL - 25MG;37.5MG

USFDA APPLICATION NUMBER - 19129

read-more

DOSAGE - TABLET;ORAL - 50MG;75MG

USFDA APPLICATION NUMBER - 19129

read-more

DOSAGE - TABLET;ORAL - 10MG;25MG

USFDA APPLICATION NUMBER - 19221

read-more

DOSAGE - TABLET;ORAL - 5MG;12.5MG

USFDA APPLICATION NUMBER - 19221

read-more

DOSAGE - TABLET;ORAL - 12.5MG;10MG

USFDA APPLICATION NUMBER - 19888

read-more

DOSAGE - TABLET;ORAL - 12.5MG;20MG

USFDA APPLICATION NUMBER - 19888

read-more

DOSAGE - TABLET;ORAL - 25MG;20MG

USFDA APPLICATION NUMBER - 19888

read-more

DOSAGE - TABLET;ORAL - 12.5MG;100MG

USFDA APPLICATION NUMBER - 20387

read-more

DOSAGE - TABLET;ORAL - 12.5MG;50MG

USFDA APPLICATION NUMBER - 20387

read-more

DOSAGE - TABLET;ORAL - 25MG;100MG

USFDA APPLICATION NUMBER - 20387

read-more

DOSAGE - CAPSULE;ORAL - 12.5MG

USFDA APPLICATION NUMBER - 20504

read-more

DOSAGE - TABLET;ORAL - 12.5MG;150MG

USFDA APPLICATION NUMBER - 20758

read-more

DOSAGE - TABLET;ORAL - 12.5MG;300MG

USFDA APPLICATION NUMBER - 20758

read-more

DOSAGE - TABLET;ORAL - 12.5MG;75MG **Federal ...DOSAGE - TABLET;ORAL - 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 20758

read-more

DOSAGE - TABLET;ORAL - 25MG;300MG **Federal R...DOSAGE - TABLET;ORAL - 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 20758

read-more

DOSAGE - TABLET;ORAL - 12.5MG;160MG

USFDA APPLICATION NUMBER - 20818

read-more

DOSAGE - TABLET;ORAL - 12.5MG;320MG

USFDA APPLICATION NUMBER - 20818

read-more

DOSAGE - TABLET;ORAL - 12.5MG;80MG

USFDA APPLICATION NUMBER - 20818

read-more

DOSAGE - TABLET;ORAL - 25MG;160MG

USFDA APPLICATION NUMBER - 20818

read-more

DOSAGE - TABLET;ORAL - 25MG;320MG

USFDA APPLICATION NUMBER - 20818

read-more

DOSAGE - TABLET;ORAL - 16MG;12.5MG

USFDA APPLICATION NUMBER - 21093

read-more

DOSAGE - TABLET;ORAL - 32MG;12.5MG

USFDA APPLICATION NUMBER - 21093

read-more

DOSAGE - TABLET;ORAL - 32MG;25MG

USFDA APPLICATION NUMBER - 21093

read-more

DOSAGE - TABLET;ORAL - 12.5MG;40MG

USFDA APPLICATION NUMBER - 21162

read-more

DOSAGE - TABLET;ORAL - 12.5MG;80MG

USFDA APPLICATION NUMBER - 21162

read-more

DOSAGE - TABLET;ORAL - 25MG;80MG

USFDA APPLICATION NUMBER - 21162

read-more

DOSAGE - TABLET;ORAL - 12.5MG;20MG

USFDA APPLICATION NUMBER - 21532

read-more

DOSAGE - TABLET;ORAL - 12.5MG;40MG

USFDA APPLICATION NUMBER - 21532

read-more

DOSAGE - TABLET;ORAL - 25MG;40MG

USFDA APPLICATION NUMBER - 21532

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12.5...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21956

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12.5...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21956

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12.5...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21956

read-more

DOSAGE - TABLET;ORAL - EQ 150MG BASE;12.5MG *...DOSAGE - TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 22107

read-more

DOSAGE - TABLET;ORAL - EQ 150MG BASE;25MG **F...DOSAGE - TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 22107

read-more

DOSAGE - TABLET;ORAL - EQ 300MG BASE;12.5MG *...DOSAGE - TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 22107

read-more

DOSAGE - TABLET;ORAL - EQ 300MG BASE;25MG **F...DOSAGE - TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 22107

read-more

DOSAGE - TABLET;ORAL - EQ 10MG BASE;12.5MG;16...DOSAGE - TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG

USFDA APPLICATION NUMBER - 22314

read-more

DOSAGE - TABLET;ORAL - EQ 10MG BASE;25MG;160M...DOSAGE - TABLET;ORAL - EQ 10MG BASE;25MG;160MG

USFDA APPLICATION NUMBER - 22314

read-more

DOSAGE - TABLET;ORAL - EQ 10MG BASE;25MG;320M...DOSAGE - TABLET;ORAL - EQ 10MG BASE;25MG;320MG

USFDA APPLICATION NUMBER - 22314

read-more

DOSAGE - TABLET;ORAL - EQ 5MG BASE;12.5MG;160...DOSAGE - TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG

USFDA APPLICATION NUMBER - 22314

read-more

DOSAGE - TABLET;ORAL - EQ 5MG BASE;25MG;160MG

USFDA APPLICATION NUMBER - 22314

read-more

DOSAGE - TABLET;ORAL - 12.5MG

USFDA APPLICATION NUMBER - 83177

read-more

DOSAGE - TABLET;ORAL - 25MG

USFDA APPLICATION NUMBER - 83177

read-more

DOSAGE - TABLET;ORAL - 50MG

USFDA APPLICATION NUMBER - 83177

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Direct Compression

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Granulation

read-more
read-more

Solubilizers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Topical

read-more
read-more

Parenteral

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Co-Processed Excipients

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Empty Capsules

read-more
read-more

Rheology Modifiers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Looking for 58-93-5 / Hydrochlorothiazide API manufacturers, exporters & distributors?

Hydrochlorothiazide manufacturers, exporters & distributors 1

77

PharmaCompass offers a list of Hydrochlorothiazide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hydrochlorothiazide manufacturer or Hydrochlorothiazide supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hydrochlorothiazide manufacturer or Hydrochlorothiazide supplier.

PharmaCompass also assists you with knowing the Hydrochlorothiazide API Price utilized in the formulation of products. Hydrochlorothiazide API Price is not always fixed or binding as the Hydrochlorothiazide Price is obtained through a variety of data sources. The Hydrochlorothiazide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Hydrochlorothiazide

Synonyms

58-93-5, Hctz, Esidrix, Hypothiazide, Hidrotiazida, Idrotiazide

Cas Number

58-93-5

Unique Ingredient Identifier (UNII)

0J48LPH2TH

About Hydrochlorothiazide

A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.

Direma Manufacturers

A Direma manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Direma, including repackagers and relabelers. The FDA regulates Direma manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Direma API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Direma manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Direma Suppliers

A Direma supplier is an individual or a company that provides Direma active pharmaceutical ingredient (API) or Direma finished formulations upon request. The Direma suppliers may include Direma API manufacturers, exporters, distributors and traders.

click here to find a list of Direma suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Direma USDMF

A Direma DMF (Drug Master File) is a document detailing the whole manufacturing process of Direma active pharmaceutical ingredient (API) in detail. Different forms of Direma DMFs exist exist since differing nations have different regulations, such as Direma USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Direma DMF submitted to regulatory agencies in the US is known as a USDMF. Direma USDMF includes data on Direma's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Direma USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Direma suppliers with USDMF on PharmaCompass.

Direma JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Direma Drug Master File in Japan (Direma JDMF) empowers Direma API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Direma JDMF during the approval evaluation for pharmaceutical products. At the time of Direma JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Direma suppliers with JDMF on PharmaCompass.

Direma KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Direma Drug Master File in Korea (Direma KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Direma. The MFDS reviews the Direma KDMF as part of the drug registration process and uses the information provided in the Direma KDMF to evaluate the safety and efficacy of the drug.

After submitting a Direma KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Direma API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Direma suppliers with KDMF on PharmaCompass.

Direma CEP

A Direma CEP of the European Pharmacopoeia monograph is often referred to as a Direma Certificate of Suitability (COS). The purpose of a Direma CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Direma EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Direma to their clients by showing that a Direma CEP has been issued for it. The manufacturer submits a Direma CEP (COS) as part of the market authorization procedure, and it takes on the role of a Direma CEP holder for the record. Additionally, the data presented in the Direma CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Direma DMF.

A Direma CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Direma CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Direma suppliers with CEP (COS) on PharmaCompass.

Direma WC

A Direma written confirmation (Direma WC) is an official document issued by a regulatory agency to a Direma manufacturer, verifying that the manufacturing facility of a Direma active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Direma APIs or Direma finished pharmaceutical products to another nation, regulatory agencies frequently require a Direma WC (written confirmation) as part of the regulatory process.

click here to find a list of Direma suppliers with Written Confirmation (WC) on PharmaCompass.

Direma NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Direma as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Direma API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Direma as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Direma and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Direma NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Direma suppliers with NDC on PharmaCompass.

Direma GMP

Direma Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Direma GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Direma GMP manufacturer or Direma GMP API supplier for your needs.

Direma CoA

A Direma CoA (Certificate of Analysis) is a formal document that attests to Direma's compliance with Direma specifications and serves as a tool for batch-level quality control.

Direma CoA mostly includes findings from lab analyses of a specific batch. For each Direma CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Direma may be tested according to a variety of international standards, such as European Pharmacopoeia (Direma EP), Direma JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Direma USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty